Product Reports Resources Pricing Login Book a demo
Power Law company profile

C4 Therapeutics

Biotech & Life Sciences · Watertown, United States · Founded 2015 · IPO 2020 Colt

C4 is building on the knowledge with synthetic chemical compounds

Valuation
$123M
Market cap · May/2026
Revenue
$36M
Latest reported FY
Featured in $1B+ revenueColt · Power Law growth-stage

Investors

20 investors on C4 Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage
Cormorant Asset Management
EG Capital Group
Novartis
Cobro Ventures
Series B+ 16 investors entered at this stage
Janus Henderson Investors
Bain Capital Life Sciences
T. Rowe Price
RTW Investments
Yonjin Venture
Sphera Funds Management
Logos Capital
Axil Capital
Lightchain Capital
Perceptive Advisors
Taiwania Capital
Commodore Capital
RA Capital Management
Nextech Invest
Mizuho Securities Principal Investment
Adage Capital

Global footprint

Where C4 Therapeutics has talent and traffic

Workforce by country
🇺🇸 United States · Watertown HQ
Book a demo for the full country breakdown
Web traffic by country
11K monthly visits
across markets
🇺🇸 United States52.7%
🇮🇹 Italy20.9%
🇮🇳 India8.2%
🇬🇧 United Kingdom6.4%
🇫🇷 France6.4%
Top 5 markets shown

Market sentiment

What the market is saying about C4 Therapeutics

An AI-synthesized read of the highest-engagement posts about C4 Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See C4 Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles